首页> 外文会议>British Crop Protection Council International Congress of the Crop Science and Technology >Integrated biological control of powdery mildew and grey mould of cucumber and tomato using Brevibacillus brevis combinations
【24h】

Integrated biological control of powdery mildew and grey mould of cucumber and tomato using Brevibacillus brevis combinations

机译:使用Brevibacillus Brevis组合的黄瓜和番茄粉状和灰色模具的综合生物控制

获取原文

摘要

Powdery mildew of cucumber caused by Sphaerotheca fusca and grey mould (Botrytis cinerea) of tomato, two important diseases of greenhouse crops, were tested for suppression of disease using integrated biological control. Brevibacillus brevis wild type(WT), a bacterial spore-former and well established biological control agent (BCA) with broad spectrum activity, was used as the main BCA for both disease systems. All agents were tested singly and in combination and also included: i) a plant extract ofReynoutria sachalinensis that induces resistance mainly against powdery mildew and ii) Pseudomonas antimicrobica, a non spore-forming bacterial BCA active against B. cinerea. B. brevis WT reduced disease by both fungal plant pathogens. Moreover, significant and heightened control of S. fusca was achieved using the B. brevis WT/R. sachalinensis combination in whole plant systems. Ps. antimicrobica also reduced disease incidence when tested using a detached tomato leaf bioassay system which was further enhanced, again significantly, when combined with B. brevis WT. These studies indicated that B. brevis is well suited to combination with other biological disease control agents to offer increased efficacy for integrated biological control.
机译:用综合生物控制测试了由番茄素孢子藓孢子和灰霉素(Botrytis Cinerea)的黄瓜和灰霉病(Botrytis Cinerea),用于使用综合生物控制抑制疾病的疾病。 Brevibacillus Brevis野生型(WT),具有广谱活性的细菌孢子前和良好的生物控制剂(BCA)作为疾病系统的主要BCA。所有药剂单独和组合测试,还包括:i)一种植物提取物的植物提取物,诱导抗粉状霉菌和II的抗性抗性抗菌剂,一种非孢子形成的细菌BCA对抗B. cinerea。 B. Brevis通过真菌植物病原体减少疾病。此外,使用B.Brevis WT / R对S. FUSCA的显着和高度控制。 Sachalinensis在整个植物系统中的组合。 PS。当使用分离的番茄叶生物测定系统测试时,抗菌剂也减少了疾病发病率,当与B.Brevis重量相结合时,再次被进一步增强,再次进行了显着提高。这些研究表明,B.Brevis非常适合与其他生物疾病对照药物组合,以提供综合生物控制的增加的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号